On August 11, local time, WHO held a routine press conference for new coronary pneumonia.
At this stage, WHO will test three new drugs: artesunate (artesunate) for the treatment of severe malaria, the drug imatinib (imatinib) for the treatment of certain cancers, and for the treatment of the immune system Disorders such as infliximab (infliximab) in Crohn's disease
Previously, the WHO initiated a "solidarity trial" at the global level, aiming to compare the safety and effectiveness of several different drugs or drug combinations in the treatment of new coronary pneumonia, in order to find effective treatments as soon as possible
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
